- Home
- WAFDP vs SCLXW Comparison
WAFDP vs SCLXW Comparison
Compare WAFDP & SCLXW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAFDP
- SCLXW
- Stock Information
- Founded
- WAFDP N/A
- SCLXW N/A
- Country
- WAFDP United States
- SCLXW United States
- Employees
- WAFDP 2208
- SCLXW 117
- Industry
- WAFDP Major Banks
- SCLXW Biotechnology: Pharmaceutical Preparations
- Sector
- WAFDP Finance
- SCLXW Health Care
- Exchange
- WAFDP Nasdaq
- SCLXW Nasdaq
- Market Cap
- WAFDP N/A
- SCLXW N/A
- IPO Year
- WAFDP N/A
- SCLXW 2021
- Fundamental
- Price
- WAFDP $16.64
- SCLXW $0.20
- Analyst Decision
- WAFDP
- SCLXW
- Analyst Count
- WAFDP 0
- SCLXW 0
- Target Price
- WAFDP N/A
- SCLXW N/A
- AVG Volume (30 Days)
- WAFDP N/A
- SCLXW N/A
- Earning Date
- WAFDP N/A
- SCLXW N/A
- Dividend Yield
- WAFDP N/A
- SCLXW N/A
- EPS Growth
- WAFDP N/A
- SCLXW N/A
- EPS
- WAFDP N/A
- SCLXW N/A
- Revenue
- WAFDP N/A
- SCLXW N/A
- Revenue This Year
- WAFDP N/A
- SCLXW N/A
- Revenue Next Year
- WAFDP N/A
- SCLXW N/A
- P/E Ratio
- WAFDP N/A
- SCLXW N/A
- Revenue Growth
- WAFDP N/A
- SCLXW N/A
- 52 Week Low
- WAFDP N/A
- SCLXW N/A
- 52 Week High
- WAFDP N/A
- SCLXW N/A
- Technical
- Relative Strength Index (RSI)
- WAFDP 41.34
- SCLXW N/A
- Support Level
- WAFDP $16.55
- SCLXW N/A
- Resistance Level
- WAFDP $16.86
- SCLXW N/A
- Average True Range (ATR)
- WAFDP 0.29
- SCLXW 0.00
- MACD
- WAFDP 0.01
- SCLXW 0.00
- Stochastic Oscillator
- WAFDP 8.48
- SCLXW 0.00
About WAFDP WaFd Inc. Depositary Shares
WaFd Inc is engaged in providing lending, depository, insurance, and other banking services to consumers, mid-sized to large businesses, and owners and developers of commercial real estate. Through the WaFd Bank, it is involved in accepting deposits from the general public and investing these funds in loans of various types, including first-lien mortgages on single-family dwellings, construction loans, land acquisition and development loans among others. The Bank also invests in certain United States government and agency obligations along with other investments and also performs insurance brokerage activities. Geographically, it operates in Washington, Oregon, Idaho, Arizona, Utah, Nevada, New Mexico, California and Texas.
About SCLXW Scilex Holding Company
Scilex Holding Co is focused on acquiring, developing, and commercializing non-opioid pain management products for the treatment of acute and chronic pain. The Company's commercial product, ZTlido (lidocaine topical system), is a prescription lidocaine topical product for the relief of pain associated with postherpetic neuralgia, which is a form of post-shingles nerve pain. It is focused on commercializing Gloperba (colchicine USP) an oral solution, a prophylactic treatment for painful gout flares in adults. The Company's three product candidates are SP-102 or SEMDEXA viscous gel formulation of a used corticosteroid for epidural injections, SP-103 a Phase 2, triple-strength formulation of ZTlido, and SP-104, 4.5 mg Delayed Burst Release Low Dose Naltrexone Hydrochloride (DBR-LDN) Capsule.